Overview

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Status:
Completed
Trial end date:
2019-12-26
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of ENERGI-F703 in subject with diabetic foot ulcers.
Phase:
Phase 2
Details
Lead Sponsor:
Energenesis Biomedical Co., Ltd.
Collaborator:
A2 Healthcare Taiwan Corporation